Companies: 10,795·Total market cap: $144.5T
Lipocine Inc.

Lipocine Inc.

LPCNNASDAQHealthcare● Active
$2.11
+$0.07(+3.19%)
Market Cap$12216382
P/E Ratio—
52W High$12.37
52W Low$1.81
Overview

Lipocine Inc. (LPCN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001535955 · LPCN · NASDAQ · as of Jun 9, 2026

Filing snapshot

804
Total Filings
S-8
Latest Form
2026-06-09
Most Recent
2013
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001535955 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-10
Fiscal Year End
Mar 10, 2026
Accession No.
0001493152-26-009411
Primary Document
form10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001535955 · Accession 0001493152-26-009411

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-07
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-04Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
S-8Employee Stock Plan Registration
S-8
2026-06-09
View
8-KCurrent Report
8-K
2026-06-04
View
8-KCurrent Report
8-K
2026-06-04
View
8-KCurrent Report
8-K
2026-05-26
View
8-KCurrent Report
8-K
2026-05-19
View
8-KCurrent Report
8-K
2026-05-18
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
8-KCurrent Report
8-K
2026-05-07
View
8-KCurrent Report
8-K
2026-05-07
View
10-QQuarterly Report
10-Q
2026-05-07
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-21
View
DEF 14AProxy Statement
DEF 14A
2026-04-21
View
8-KCurrent Report
8-K
2026-04-21
View
8-KCurrent Report
8-K
2026-04-02
View
Showing 1–15 of 656 filingsForm 4 / 144 hidden· 804 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001535955  |  Exchange: NASDAQ · Healthcare

Lipocine Inc. (NASDAQ: LPCN) has submitted 804 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2013. As a Healthcare sector company with CIK 0001535955, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Lipocine Inc.'s most comprehensive regulatory disclosure. The most recent Lipocine Inc. 10-K was filed on 2026-03-10 for fiscal year ending 2026. Historical LPCN 10-K annual reports are available from 2011 through 2026.

Investors researching Lipocine Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ANL SEC Filings →EDSA SEC Filings →BLRX SEC Filings →PMN SEC Filings →ADAP SEC Filings →LNAI SEC Filings →OSRH SEC Filings →MBRX SEC Filings →
→ LPCN Financials→ LPCN Earnings→ LPCN Insider Trades

Frequently Asked Questions

LPCN SEC Filings · 8 questions

Lipocine Inc. (LPCN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 804 filings and access original documents at no cost. Lipocine Inc.'s CIK is 0001535955.

LPCN SEC filingsLipocine Inc. SEC documentsfind LPCN 10-K